
The Delhi High Court imposed a ₹1 cost on Niva Bupa Health Insurance after finding the company had misused its Intellectual Property Division jurisdiction. According to Justice Anup J Bhambhani, naming a company during criticism does not automatically infringe its trademark. This was particularly relevant because Vishal Rattewal was not using the trademark for business purposes, as he was neither involved in insurance nor connected with that business. The court observed that filing such a suit amounts to misuse of the special jurisdiction of this court under the Intellectual Property Division, stating that "since the suit was filed and pressed, this court is of the view that filing of such suit amounts to misuse of the special jurisdiction of this court under the Intellectual Property Division."
The dispute began with a medical insurance claim involving consumer Neeraj Kumar, who filed a consumer complaint against Niva Bupa. On 9 October 2024, a consumer commission in Haryana ruled in Kumar's favour, with the commission located in Charkhi Dadri. The court's order included general observations about medical insurance companies. Niva Bupa alleged that Rattewal had later published offensive content based on those proceedings and objected to his references to an August 2026 regulatory order from the Insurance Regulatory and Development Authority of India (IRDAI). The regulator had barred Niva Bupa from opening new business locations for six months due to regulatory violations.
Niva Bupa and its advocate had filed the lawsuit against Rattewal, seeking removal of his content from Instagram, Facebook, YouTube, and X, along with an apology, ₹5 crore in damages, and reimbursement of legal expenses. The insurer argued that Rattewal's posts had damaged its reputation and attracted social media engagement. It also claimed that he had infringed its registered trademark. However, the court questioned whether these allegations amounted to trademark infringement under the law, distinguishing naming a company in critical posts from using its trademark commercially. The court noted that simply identifying the insurer through its name did not establish trademark use in trade, as reported by Bar and Bench.
The court found no dispute regarding the infringement of intellectual property rights, meaning its specialised IP Division could not hear the case. The judge stated that filing and pursuing this lawsuit misused that division's special powers. The ₹1 cost followed this finding of misuse, with the court initially directing that the lawsuit be returned for filing before an appropriate court. It later allowed the plaintiffs to withdraw their suit, permitting them to file a fresh civil lawsuit concerning the same dispute, subject to paying ₹1 to Rattewal. The withdrawal permission left the plaintiffs free to pursue a fresh civil case before another appropriate court.
The ₹1 fine was described as a gentle warning rather than punishment, serving as a clear message that large corporations cannot misuse specialised courts to intimidate critics. The order addressed whether the IP Division was the correct forum for this lawsuit, with the withdrawal permission leaving the plaintiffs free to pursue a fresh civil case before another appropriate court. This ruling establishes important precedent regarding the proper use of specialised court jurisdictions in intellectual property disputes, particularly in cases involving online influencers and their critical commentary about companies.